Form 4: Glaukos Corp Executive Exercises Stock Options After Performance Targets Met

A Glaukos Corp executive, Alex R. Thurman, exercised stock options after the company met certain operational targets.

Summary

• Alex R. Thurman, a Senior Vice President and Chief Financial Officer at Glaukos Corporation, exercised stock options on December 30, 2024.
• These options were part of a grant from March 24, 2022, which vested upon the achievement of pre-determined operational targets.
• The Compensation, Nominating and Governance Committee determined that certain targets were met, allowing for the vesting of 3,660 shares.
• 50% of these options will vest in March 2025, and the remaining 50% will vest in December 2025.
• Following this transaction, Mr. Thurman directly owns 33,852 shares.

Sentiment

Score: 7

Explanation: The document indicates positive performance as operational targets were met, leading to the vesting of stock options. This is a positive sign for investors, but it is a routine transaction.

Positives

• The vesting of stock options indicates that Glaukos Corp has achieved certain operational targets set by the company.
• The exercise of options by a key executive suggests confidence in the company's future performance.

Future Outlook

The vesting schedule indicates that the executive's compensation is tied to the company's continued performance, with further vesting in March and December 2025.

Industry Context

This is a standard practice for incentivizing executives in publicly traded companies, aligning their interests with those of shareholders by tying compensation to performance.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation in the technology and healthcare sectors, similar to companies like Alcon and Johnson & Johnson.
• The vesting schedule tied to operational targets is also a standard practice to ensure executives are focused on achieving company goals, similar to performance-based compensation plans at companies like Medtronic.
• The exercise price of $55.18 is typical for stock options granted to executives, and the number of shares is consistent with grants at similar companies.

Stakeholder Impact

• Shareholders may view the vesting of stock options positively, as it indicates the company is meeting its operational goals.
• The executive's increased ownership aligns his interests with those of shareholders.

Next Steps

• The next vesting dates for the stock options are March 2025 and December 2025.

Key Dates

Keywords

stock options, executive compensation, vesting, operational targets, Glaukos Corp, insider trading, SEC Form 4